Transcatheter Aortic Valve Replacement (TAVR)
CLEARWATER, Florida (February 22, 2014) - Morton Plant Hospital is expanding its Valve Clinic and Transcatheter Aortic Valve Replacement (TAVR) programs by utilizing the self-expanding Medtronic CoreValve. Morton Plant is the nation's first hospital, not previously involved in the Medtronic research study, to implant this new valve. Morton Plant's Heart Team has successfully completed six CoreValve implants since the FDA's January approval of the valve for the treatment of severe aortic stenosis.
The CoreValve utilization is part of the legacy of firsts for the TAVR program since Morton Plant became the first hospital in Tampa Bay to offer the procedure two years ago. Learn more...
About Transcatheter Aortic Valve Replacement (TAVR)
An innovator in heart care, Morton Plant Hospital is the first hospital in Tampa Bay, Florida, approved to offer the newly available Transcatheter Aortic Valve Replacement (TAVR) procedure to patients with severe aortic stenosis. The TAVR team at Morton Plant Hospital is one of the few to offer alternative vascular access to patients with small vessels. This expertise in small vessel access may enable those patients who were previously told they were not candidates to proceed with TAVR therapy at Morton Plant Hospital.
The new TAVR procedure, also called TAVI (Transcatheter Aortic Valve Implant), is a minimally invasive alternative to traditional open-heart surgery. The procedure enables a collapsible aortic heart valve to be implanted in the aortic valve by using a catheter and entering through the femoral artery in the thigh. TAVR not only offers an improved quality of life for the patient, but it is also an alternative treatment option for high-risk patients with critical aortic stenosis who may otherwise not be candidates for open aortic valve replacement.
TAVR procedures are performed at our Valve Clinic in Clearwater, Florida, in the brand new, state-of-the-art Hybrid Operative Suite.
Step 1: Catheter is introduced into the diseased valve.
Step 2: Valve is put in place and expanded with a balloon.
Step 3: Balloon is deflated, catheter is removed and the new valve remains in place.
About Aortic Stenosis
Approximately 1.5 million people in the United States suffer from aortic stenosis, which is a progressive disease characterized by abnormal narrowing of the aortic valve of the heart. This can obstruct blood flow to the body. Of those diagnosed with the condition, approximately 250,000 people suffer from severe symptomatic aortic stenosis and may experience debilitating symptoms that can restrict normal activities, such as walking short distances or climbing stairs.
While many of these individuals can benefit from aortic valve surgery, only about two-thirds of them undergo the procedure each year. Many patients are not treated because they are deemed inoperable for surgery, have not received a definitive diagnosis, are concerned about the risks of surgery, or assume that the condition is simply a normal part of the aging process.
Patients who do not undergo an aortic valve replacement (AVR) do not have any other effective, long-term treatment option to prevent or delay the progression of their disease. Without the procedure, severe aortic stenosis is life-threatening. Research indicate that about half of all patients diagnosed with symptomatic aortic valve stenosis patients will not survive more than an average of two years after the onset of symptoms.
Symptoms of severe aortic stenosis include:
- Chest pain or tightness, also called angina
- Severe shortness of breath, leading to gasping – even at rest
- Extreme fatigue, especially during periods of activity
- Lightheadedness and/or fainting
- Difficulty exercising
- Rapid or irregular heartbeat
Individuals throughout the Tampa Bay area can learn more about transcatheter aortic valve replacement and the Valve Clinic at Morton Plant Hospital in Clearwater, FL. To contact the Valve Clinic Coordinator, please call (855) 44-VALVE (855-448-2583). Physicians can fax a referral form to (727) 462-7261.
View our 2012 Cardiovascular Surgery Outcomes Report.
Minimally Invasive Heart-Valve Procedure Shows Promise